New Construction Apartment Via Aurelia Da 305

DOMUS AURELIAE - In the splendid Aurelio neighborhood, on Via Aurelia at the height of Ergife, we offer for sale an apartment in a building under construction with delivery in December 2027. The building is arranged over seven floors above ground plus a garage and cellars on the S1 floor. The project involves the creation of a building where the dialogue between materials and geometries generates a strong architectural character. Isotex construction system that guarantees solidity, thermal and acoustic insulation, and seismic resistance, thus high energy performance buildings. The apartment, located on the 3rd floor, consists of a living room with dining area, a habitable kitchen with large openings towards the outside that favor natural light and ventilation, a master bedroom with generous spaces, a second versatile and functional room that can be used as an office or a room for children, and two bathrooms. The property is completed by a large balcony of about 52 sqm. Parquet flooring for interiors or porcelain stoneware, home automation system, video intercom, integrated central vacuum, private gym. Possibility of purchasing a garage and cellar. Domus Aureliae: an idea of an evolved and contemporary home, where every detail is designed to offer well-being, functionality, and authentic comfort. For information, contact Rezza Real Estate Spa Piazza di Spagna 32 Rome Tel. 06 474951. The confidentiality of the information requires professional seriousness in behavior, therefore any details will be communicated only to directly interested parties by appointment. There is no intention to collaborate with intermediaries or representatives of unknown third parties. The information provided has no contractual content. The dimensions in terms of volumes and commercial square meters are purely indicative. The data regarding commercial information related to the published listings comes directly from the real estate agency from the respective mediation assignments. Rezza declines any responsibility for the presence of any erroneous indications.